That GM-CSF itself might be a useful target for immune treatment in RA individuals has been reported recently; in this study treatment having a human being monoclonal antibody against GM-CSF was shown to be efficacious in individuals with active RA [31]

That GM-CSF itself might be a useful target for immune treatment in RA individuals has been reported recently; in this study treatment having a human being monoclonal antibody against GM-CSF was shown to be efficacious in individuals with active RA [31]. Given the importance of macrophages and neutrophils for the Continue Reading